A Prospective Comparison of Methadone, Fentanyl, and Morphine for Post-laparotomy Epidural Analgesia
Information source: Hadassah Medical Organization
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Post Laparotomy Pain Treatment
Intervention: epidural morphine via PCEA (Drug); epidural fentanyl via PCEA (Drug); epidural methadone via PCEA (Drug); intravenous morphine via PCA (Drug)
Phase: N/A
Status: Not yet recruiting
Sponsored by: Hadassah Medical Organization Overall contact: Hadas Lemberg, Phd, Phone: 0097226777572, Email: lhadas@hadassah.org.il
Summary
The current study aim is to compare between the opioids morphine, fentanyl and methadone in
terms of efficacy and side effects profile when administered epidurally for pain management
after laparotomies. Intravenous morphine will also be used. The outcomes of that method will
be compared to those obtained using epidurally administered opioids, as this is another
commonly used postoperative pain relief method.
Clinical Details
Official title: A Prospective Double Blind Randomized Comparison of Methadone, Fentanyl, and Morphine for Post-laparotomy Epidural Analgesia.
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Variable stimuli, fixed response: measurement of pain tolerance by gradual increase of temperature (quantitative sensory testing (QST))as compared to baselineFixed stimuli, variable response: measurement of reaction to fixed temperature by visual analog scale (VAS) as well as Variable stimuli, variable response (electrical stimuli)as compared to baseline. patient controlled epidural analgesia (PCEI)/patient controlled analgesia (PCA)dose frequency as compared to baseline
Secondary outcome: Measurement of opioid concentration in plasma as compared to baselinePupillometry as compared to baseline Respiratory rate as compared to baseline Nasal capnography at rest as compared to baseline Report of adverse effects' severity as compared to baseline Report of pain severity- at rest, cough and deep breathing as compared to baseline
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
* Elective laparotomy
Exclusion Criteria:
- Subjects with diabetes mellitus, other neurological or systemic disease associated
with altered sensory perception
- Illicit drug abusers
- Chronic use of pain medication
- Inability to understand consent form
- Age < 18
- Renal failure (Clcr<50 ml/min)
- Chronic use of drugs that can alter plasma levels and\or effect of the study drugs
- Corrected Q-T interval(QTc)=450msc and above
- Contra-indication for epidural catheter insertion
- Pregnancy
Locations and Contacts
Hadas Lemberg, Phd, Phone: 0097226777572, Email: lhadas@hadassah.org.il
Hadassah Medical Organization, Jerusalem 91120, Israel; Not yet recruiting Hadas Lemberg, Phd, Phone: 972507874098, Email: lhadas@hadassah.org.il Elyad Davidson, MD, Phone: 972507874098, Email: Edavidson@hadassah.org.il Elyad Davidson, MD, Principal Investigator
Additional Information
Starting date: April 2013
Last updated: April 8, 2013
|